Professor Anna DeFazio heads the Gynaecological Oncology research group at the Centre for Cancer Research, the Westmead Institute for Medical Research (WIMR). Anna holds the Sydney-West Chair in Translational Cancer Research, University of Sydney, at Westmead Hospital, and has a long-standing commitment to translational research with an emphasis on improving treatment outcomes for women with ovarian cancer. She completed her PhD at the Ludwig Institute for Cancer Research, University of Sydney and undertook postdoctoral studies at the Garvan Institute before establishing a program of ovarian cancer research at Westmead. Anna is Director of the Centre for Cancer Research at WIMR, Co-Deputy Director of the Sydney-West Translational Cancer Research Centre and chairs the University of Sydney Cancer Research Network. Anna heads the INOVATe program and is a member of a number of collaborative consortia and clinical trials groups including the Australian Ovarian Cancer Study (AOCS) and the Australia and New Zealand Gynaecological Oncology Group (ANZGOG).